8th Oct 21-Pharmaceuticals Industry by The Global Hues Magazine

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

From National To Global We Engage With People To Tell Their Stories

WELCOME To The Digital Edition of

Subscribe to our E-Magazine NOW! Visit www.theglobalhues.com

2 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

Contents

Vol 1 | Issue 15

10 COVER STORY

October 2021

16 NEWS

Ramesh C Juneja Founder & Executive Chairman

Around the Globe in 5 Minutes

18 TECHNOLOGY

Artificial Intelligence Empowering

The Pharma Industry Today And Tomorrow

24 22

Alkem Laboratories

Extending Healthcare Beyond Boundaries 4 | TheGlobalHues | Vol. 1 | Issue 15 | October 2021

Arch Pharmalabs Serving Society Through Trusted Lifesaving Products

Aurobindo Pharma

Divi’s Laboratories

Ipca Laboratories

Committing A Healthier & Happier Life

Ensuring Uninterrupted Supply Of High-Quality APIs

Strengthening Global Healthcare

Shocking Fact About Google

Indoco Remedies

Sun Pharma

We Bet You Didn’t Know How Does Google Earn Money?

Cadila Pharmaceuticals Ensuring Optimum Health Outcomes For All

Upgrading Healthcare Access With Quality Medicines

Excelling In Developing Generics And Technology Complex Products

Co-Working Spaces

A New Normal Post Covid-19

Zydus Cadila

Bringing Innovative Pharmaceutical Solutions To Life TheGlobalHues | Vol. 1 | Issue 15 | October 2021

Intellect Quotes On

Lifestyle

Opportunity

Top 5 Expensive Motorbikes In The World

47 Listing

10 Most Valuable Pharmaceutical Companies In India

54 Travel

Meghalaya

The Abode Of The Clouds

50 Health

5 Healthy Foods That Every Bootstrapped Entrepreneur Should Eat

6 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

Editor’s Note F

rom the past few years, the pharmaceutical industry is firmly establishing itself as a vital industry by creating exciting and ground-breaking treatments. If we take a look at the past 50 years of data, the contribution of the pharmaceutical sector to the entire globe has been phenomenal. This industry has been successful in determining the causes of many deadly and lethal diseases. That is why the pharma sector is gaining a lot of prominence in the market. The continued growth in the biologics field, technological innovations, and the increasing efficiency in disease control are adding substantial growth to the valuation of the pharma industry. Pharmaceutical companies are continuously and consistently striving towards delivering innovative and effective solutions that help people live healthier and happier lives. To appreciate the commendable and dedicated work of the pharmaceutical industry, we present this edition of The Global Hues magazine. It will cover different attributes, insights, and growth parameters that left a bold mark on the pharmaceutical sector. It will also showcase the success stories, journeys, challenges, and progress of different leaders in the pharmaceutical sector. Hope you have a splendid time reading this issue! The Global Hues

Editorial@theglobalhues.com

Vol 1 | Issue 15 | October 2021 Publisher: The Global Hues CEO: Himanshu Tyagi Editor-in-chief: Tannishtha Mukherjee Copy Editor: Priyanka Tyagi Editorial Team: Kusum Vats, Aditi Gautam, Anushka Trivedi, Shreya Malakar, Vanshika Dhameja Design Team: Jai Prakash, Himanshi Jain Digital Team: Shubham Garg, Himanshu Gupta, Amit Sharma ------------------------------------------------Head of Sales & Marketing: Chetan Kaushik Sales Team: Annu Vimal, Ritu Chauhan, Anubha Singh Chauhan, Anushka Gupta, Sanchit Rathi, Shubham Goel Data & Research: Naval Kishore, Kunal Sharma Marketing & PR: Krishiv Kumar PR@theglobalhues.com Advertisement: Mayank Gulati Subscription: Maniraj Reddy subscription@theglobalhues.com HR: Simran Khanna Corporate Office Address: A-204, Third Floor, Vikaspuri, New Delhi-110018 Ph. no. : +91 9871258991 Email: info@theglobalhues.com Cover Price: ₹199/The Global Hues does not accept responsibility for returning unsolicited materials & photographs. All unsolicited material should be accomplished by self-addressed envelope & sufficient postage. All disputes are subject to exclusive jurisdiction of competent courts and forums in Delhi/New Delhi only. © 2021 Publisher, Reproduction in whole or a part throughout the world, including image text or anything without written permission from the publisher, is prohibited. All rights reserved.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

8 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

Make A Phenomenal Start With The Global Hues The Better Way To Grow Your Business CONNECT WITH US: Website - www.theglobalhues.com PR & Communications - pr@theglobalhues.com; info@theglobalhues.com Contact No - 8700280047 ; 9871258991 Also Available On:

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

Ramesh C Juneja

Founder & Executive Chairman Mankind Pharma

10 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

COVER STORY

Mankind

Pharma

Enabling A Healthier World

stablished in the year 1995, Mankind Pharma is a leading and valuable pharmaceutical company that desires to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy the urgent needs of patients. The company takes pride in the success of a wide range of products ranging from OTC, Pharma, and FMCG brands such as Gas-O-Fast, Manforce Condoms, Unwanted 72, Prega News, Adiction, Manforce Staylong Gel, Kaloree 1, Manforce Tablets, and many others. Scientists at Mankind Pharma have recently introduced Dydroboon in the female infertility segment after 9 years of tireless research work in the Research and Development Center. It has become the first Indian company to launch Dydrogesterone. It has also launched a novel patented drug Remogliflozin with the name SGLTR in 2019 for the better management and handling of Diabetes.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 11

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

Ramesh C Juneja is the Founder and Executive Chairman of the company. He founded the company with his younger brother Rajeev. In the year 2011, he was presented with the ‘India Business Icon (Pharma) Award’ by Network 18. His consistent efforts to provide highquality products at an affordable price to consumers have revolutionized the Indian pharmaceutical industry.

on promoting innovation, knowledge, and leadership skills. Developmental capabilities like New Drug Discovery and Research (NDDR), APIs, Formulations and Development, Analytical Research and Development, Clinical Research & Biopharmaceutics, Regulatory Affairs, Biotechnology, and Intellectual Property Management are undertaken in the center.

PRODUCTS

Understanding the needs of the customers, Mankind Pharma develops superior quality products at affordable prices. The product portfolio of the company includes a wide variety of medical streams such as Neurology, Diabetology, Cardiology, Gastroenterology, Ophthalmology, Pulmonology, Dermatology, Gynecology, and many more. Prescription Medicines: Mankind Pharma’s super quality medicines are recommended by both medical experts as well as trusted customers. With an innovative approach, the company is providing over 1000 supreme quality medicines in 22 forms to serve mankind and humanity. OTC Products: With a cutting-edge research center, the best manufacturing units, and marketing excellence, Mankind Pharma offers multi-faceted products across different categories such as oral contraceptives, pregnancy detection cards, antacids, artificial sweeteners, and many more. Veterinary Medicines: The company manufactures extensive pet healthcare products in certified plants to ensure high efficiency and quality. Its veterinary products have witnessed success in the areas of poultry, dairy products, and companion healthcare.

RESEARCH AND DEVELOPMENT

Focusing on promoting innovation, the aim of Mankind Research Center is to provide excellent quality products and pioneer in the fields of new molecular research and API development. Its state-of-the-art Research & Development Center is located in Manesar and is administered by more than 350 leading and experienced scientists from various fields. They solely focus

12 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

1. Active Pharmaceutical Ingredients Currently, Mankind markets 1000 products and 200+ products are under development. It develops and delivers innovative products at an affordable price to all its customers. It develops high-quality Active Pharmaceutical Ingredients to help patients get access to innovative and affordable medicines. The company formulates NCEs, generic APIs, steroids,

COVER STORY Advanced Intermediates, for domestic, semi-regulated, and regulated markets. In order to diversify its product range and product mix, it manufactures a variety of APIs using a combination of processes. The company has 3 state-of-the-art R&D Centers where more than 350 scientists work continuously to synthesize a cost-effective and innovative process. 2. Formulation Research and Development Mankind has an experienced team of trained and skilled scientists, chemists and technicians, who work relentlessly to solve tough challenges and provide innovative solutions for patients around the world. The company develops many generic products of various dosage forms like: Multilayer tablets, compression-coated tablets, and inlay tablets Syrups and suspensions Ointments, creams, and gel preparations Pellets of immediate-release, sustained-release, and delayed-release Dry syrup technologies Taste-masking technology Sterile preparations Effervescent technologies Ophthalmics Including nano-emulsion technologies 3. Analytical Research and Development It includes pre-formulation, stability and degradation studies on APIs and other drugs, and preparation of technical dossiers for registration in India and other countries of the world. The Analytical Development team is assigned to develop and validate analytical methods, do environmental monitoring and analysis, provide quick and accurate analytical support to API’s formulation divisions, evaluate manufacturing plants, and provide quick, accurate, and cost-effective analytical solutions as per plant requirement. 4. Discovery of New Drugs Talented and experienced scientists at Mankind Pharma have comprehensive capabilities for clone/cell line development, upstream and downstream process development, and analytical research. Drug discovery includes

identifying and developing new therapies for disease areas such as Metabolic disorders, Liver and auto-immune disorders. New Drug Discovery and Research (NDDR) Department has capabilities to conduct drug discovery and development from concept to IND (Investigational New Drug Application) enabling preclinical and clinical studies

MANUFACTURING CAPABILITIES

The company has 21 state-of-the-art manufacturing facilities in various areas like Himachal Pradesh, Sikkim, Rajasthan, and Paonta Sahib. Mankind TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 13

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

manufacture 15 million and 1.2 million Ampoules and Vials per month respectively. Shree Jee Laboratory in Behror Rajasthan: Spread in a total area of 17680 sq. meters, it is built with adequate space and operational convenience. This site has an installed capacity of 115 KL. J K Print Packs: This unit has two different manufacturing facilities. It is spread in a total area of 8160 sq, meters. One is for manufacturing printing items like mono cartons, corrugated boxes, and sheets. The second one is for manufacturing tablets/capsules/Dry Powder/Dry Syrup. Manufacturing Unit - Sikkim: This unit manufactures extended release tablets/capsules, and bilayered tablets. Spread in a total area of 43,000 sq meters, it can manufacture 250 million tablets and, 40 million hard gelatine capsules per month.

CORPORATE SOCIAL RESPONSIBILITY

With the philosophy of “serving life”, the Mankind group commits to growing in a socially and environmentally responsible way. Therefore, it performs various CSR activities: Giving medical assistance by organizing camps and distributing free drugs.

Pharma has always invested in building modern manufacturing facilities to meet the growing demands of society. All its manufacturing facilities are designed as per the cGMP and FDA guidelines and approved by WHO-GMP. Modern and Systematized Infrastructure Its facilities have four change room concepts and segregated de-humidified areas for manufacturing moisture-sensitive products. For in-sterile facility core areas, stainless steel panels are used. All its facilities are set up with a water system with interlocking Supervisory Control and Data Acquisition (SCADA), velocity monitoring, power backup, and online conductivity.

14 | TheGlobalHues | Vol. 1

State-of-the-art Facilities The company has developed separate centers for various dosage forms like tablets, hard and soft gelatin capsules, syrups & suspensions, orally disintegrating films, sachets, injectables, and creams & ointments. It manufactures high-quality Ayurveda and supplementary products along with Natural Rubber Latex Condoms, Nutraceuticals & Cosmetics. Some of its well-known manufacturing units are: Manufacturing Unit 1 in Paonta Sahib: Spread in a total area of 18000 sq. meters, this manufacturing unit produces Vials and Ampoules injectables. It can

| Issue 15 | October 2021

Organizing awareness programs for the well-being, security, and welfare of people from all age groups. Enacting green initiatives to preserve nature. The programs are designed to meet the needs of society and make the world a happier and healthier place.

ENVIRONMENT POLICY

Mankind Pharma follows the policy for conserving environment and ensuring health, and safety. This is done through: Compliance: It complies with all the laws, and regulations applicable to the operations. Safety: It ensures a safe working environment for everyone- contractors, employees, visitors, and other stakeholders.

COVER STORY

Improvement: It provides required resources for improvement in the EHS management system with an aim of boosting performance. Encouragement: It encourages all its employees and contractors to report all incidents including near misses by taking appropriate corrective and preventative actions in a time-bound program. Communication: It adopts best practices in the EHS management system through excellent communication and delivers required training to all employees and contractors. Conservation: It strictly works in accordance with energy conservation, recovery, reduction, recycling, and reuse of waste to minimize risks and hazards.

MISSION AND VISION OF THE COMPANY

The mission of Mankind Pharma is to provide cost-effective, innovative based, and superior-quality pharmaceutical products worldwide, to improve the lives of the patients. The company sees a vision to become a global pharmaceutical company, most admired for its Affordability, Quality, and Accessibility of products.

AWARDS AND MILESTONES

Since the inception of the company, Mankind Pharma has received many awards because of its commendable work in the pharma sector. Some of the coveted awards include:

The ‘Smart Exporter- Pharmaceuticals’ Award by Gateway Media Private Limited in 2018. The ‘Dream Companies to Work For to work for’ & ‘Fun At Work’ Award in Asia’s Best Employer Brand Awards 2017 (8th Edition) hosted by World HRD Congress in 2017. India’s 50 Great Workplaces’ title in 2014 for being a workplace that cares for people, and has a great leadership culture.

Honored for the spirit of entrepreneurship with ‘Udyami Samman’ by Axis Group and Zee News (UP) in 2011. Today, Mankind Pharma has become one of the leading global pharmaceutical companies that is vertically integrated with a presence in the API and formulation segments.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 15

Around the Globe NEWS

AFRICA

EUROPE

A 10.5GW solarplus-wind project is under development in Morocco’s Guelmim Oued Noun region, with 3.6GW of this to be exported to Great Britain. Morocco is currently aiming for 52% of its installed capacity to be renewables by 2030.

BP and Eni are seeking to raise up to $2 billion for their emerging oil and gas joint venture in Angola as they look to reduce debt to help build up renewables businesses, banking and industry.

Algeria plans a new investment law to improve its business climate and attract foreign investors. The intention is to boost the non-energy sector, said the Prime Minister Ayman Benabderrahmane. AUSTRALIA Australian vape manufacturer Liber Pharmaceuticals positions itself to take a large slice of a fast-growing market due to changes in federal legislation around accessing nicotine vaping products (NVP) With an aim to ensure an access pathway to safe NVPs, Australia is the first country to make these changes.

16 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

Geely owned Volvo Cars aims to raise $2.9 billion through an initial public offering. “Volvo Cars believes that its unique structure and focused strategy makes it one of the fastest transformers in the global automotive industry, with mid-decade ambitions dedicated to electrification, sustainability and digitization.” said the company.

A British groceries and general merchandise retailer Tesco launches its zero-waste trial at 10 stores in England. Customers will be able to buy common household goods in reusable packaging that can be returned to the store to be used again. Global technology company HCL Technologies signs a multi-year contract with Belgium-based telecommunications company Proximus to transform its data center business and create a resilient digital foundation.

ASIA

in Minutes

Zurich Malaysia’s general insurance and general takaful businesses launches the Covid-19 Business Assistance Programme. The MYR2 million fund will provide complimentary coverage for Covid-19related expenses for all eligible customers.

Reliance Industries sets up a subsidiary in the United Arab Emirates (UAE) for trading in crude oil, petroleum, petrochemical products and agricultural commodities.

AMERICA

Tata Steel sells Singapore unit NatSteel for Rs. 1275 crore. The divested business, which had posted a revenue of Rs 2852 crore in FY21, had a negative net worth as on March 31, 2021. Japan aims to expand renewable energy to meet a 2030 target of a 46% emissions cut. “I would like to promote the maximum adoption of renewable energy, thorough energy conservation and the restart of nuclear power plants with the highest priority on safety,” said Japanese minister Koichi Hagiuda.

Russia develops a software that monitors social media to help authorities prevent young people from harming themselves and others. “The system is used to monitor the open circuit of the Russian-speaking segment of popular social networks,” said Russia’s youth affairs agency Rosmolodyozh.

Telecom group Bharti Airtel plans to invest $673 million on data centre expansion to meet customer demand in and around India. “There is a huge potential and huge demand (for data centres) which is expected in th next three to four years,” said Airtel Business Chief Executive Ajay Chitkara.

A leading financial services company Sun Life Financial plans to buy U.S. benefits firm DentaQuest for $2.5 billion in the biggest deal since 2001. The deal will add about $100 million to its U.S. underlying income in its first full year after closing.

McDonald’s Corp targets to cut greenhouse gas emissions to net-zero by 2050, from the beef in its burgers to the light bulbs in its restaurants.“We believe we have both a privilege and a responsibility to help lead on issues that matter most in communities,” said McDonald’s President and CEO Chris Kempczinski. Automobile manufacturer company Ford announces $11.4 billion investment in electric vehicle plants in US to build its biggest ever factory in Tennessee, and two battery parks in Kentucky.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 17

TECHNOLOGY

Artificial Intelligence Empowering

THE PHARMA INDUSTRY Today And Tomorrow

The global AI in the pharma market is expected to grow from $0.91 billion in 2020 to $1.27 billion in 2021 at a compound annual growth rate (CAGR) of 39%.

The global AI in the pharma market is expected to reach $5.94 billion in 2025 at a CAGR of 47%. This growth is projected due to many companies resuming their operations and adapting to the new normal caused because of the pandemic.

ROLE OF AI AND BIG DATA

Research conducted by GlobalData, a leading data and analytics company revealed that

ave Waters once said, “Predicting the future isn’t magic, it’s artificial intelligence.” That’s the power of AI. Artificial intelligence is one of the fastest-growing and expanding technologies on the planet today. Because of the need of the hour, the pharmaceutical industry is ramping up its artificial intelligence use at a rate that might help the sector in ensuring faster medical treatments. In recent years, the role of AI in pharmaceuticals is increasing. AI has revolutionized how scientists combat diseases, come up with new medications and discover theories in the pharmaceutical sector in the last five years.

18 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

28% of companies will be using AI and big data/analytics to optimize drug discovery and development processes in the next two years, while 32% would be relying on big data/analytics to streamline sales and marketing.

SOME OTHER KEY FINDINGS OF THE REPORT ARE: AI and big data will play a major role in optimizing pharmaceutical drug discovery and development processes, as indicated by 24% and 25% of global healthcare industry professionals, respectively 23% of respondents confirmed that their companies were currently using AI to enhance drug discovery and development processes, while 28% expected to continue or start using AI in the next two years 27% of respondents believed that big data would play a major role in optimizing marketing and sales More than 30% of respondents were currently using big data in marketing and sales and expected to continue using it in the next two years The implementation of AI in sales and marketing is expected to achieve a bigger uptake in the next few years.

KEY AREAS WHERE AI HAS HELPED THE PHARMA INDUSTRY

Artificial intelligence is progressively being used in the biopharma sector, right from early-stage drug development to prescription treatment choices, with a predicted market volume of $10 billion by 2024, encompassing AI-based medical imaging, genomics, drug discovery, diagnostics, and personal AI assistants. Some of the prominent areas where AI has helped the pharma market are:

Improvements in drug discovery, approval, and design

Improvements In Drug Research And Manufacturing

Ensuring Intelligent Drug Supply Chain

KEY AREAS WHERE AI HAS HELPED THE PHARMA INDUSTRY

01. Improvements in drug discovery, approval, and design

AI usage in the pharma business not only reduces the time to test a medicine but also for drug approval as well. It takes less time to reach the market thereby meeting the market demands earlier than expected. This also leads to cost reductions and lowering expenditures for patients. RNA and DNA detection can be done swiftly with the aid of AI.

02. Improvements In Drug Research And Manufacturing

Pharma companies, if use Artificial intelligence, can cut design time, enhance production reuse, reduce material waste, perform predictive maintenance, and much more. It also improves the manufacturing process of medicines not only by increased productivity but also by ensuring the completion of each activity with precision.

03. Ensuring Supply Chain

Intelligent

Drug

The supply chain of this industry is made up of many complicated procedures but AI creates solutions for this as well. AI can help with making decisions, organizing operational efficiency, and establishing a cost-effective and flourishing supply chain. AI also holds the potential to address some of the major challenges in pharmaceutical cold chain management. A study conducted by McKinsey & Company in 2013 found a severe lack of agility in the supply chains of the pharmaceutical sector. The report noted that the replenishment times from manufacturer to distribution centers averaged around 75 days for the pharma industry while only 30 days for other industries, therefore reported the need for better transparency around logistics, costs, distribution, and warehousing. Here, the role of AI comes into play. Assuring drug efficacy, patient identity and chain of custody integrated with supply chain agility are the

Transformation In Pharmacovigilance And Drug Safety

Improvements In Drug Adherence And Outcomes

vital factors where the role of AI comes into play for the pharmaceutical industry.

04. Transformation In Pharmacovigilance And Drug Safety

The World Health Organization (WHO) defines pharmacovigilance (PV) as “the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem.” Here, AI brings up possibilities for solving categorization and prediction issues. With the use of AI, companies can analyze Postmarketing Surveillance (PMS) data faster than before. As this will ensure quick discovery of nuanced insights from extensive batches of data, it will improve patient safety while reducing the risk among drug manufacturers.

05. Improvements In Drug Adherence And Outcomes

Medical adherence is a very important aspect for any treatment to yield results. Unfortunately, there aren’t enough resources to monitor and provide remote treatment to patients. Thankfully, AI has started gaining popularity in the field of adherence monitoring. This can be achieved through a variety of ways like the use of internet-of-things devices and centralized data collection.

06. Improvements In Regulatory Information Management

One of the roadblocks to success for the pharmaceutical industry most prominently includes the regulatory environment. To secure medical approval, pharma

Improvements In Regulatory Information Management

companies need accurate interpretation and communication inside and outside the organization. Artificial intelligence can solve this problem too. Advanced AI can offer regulatory affairs professionals with insightful data to ensure workflow enhancement. This can be ensured by evaluating current and updated federal regulations governing drug developmental procedures and methods.

FINAL WORDS

Lack of skilled professionals may cause hindrance in the growth of artificial intelligence in the pharma industry. In 2019, a famous job portal Indeed revealed that AI job postings increased 29.1 % as compared to last year but with no uncertainty due to the AI skills gap, AI-related roles decreased by 14.5% over the same time period. So, the shortage of appropriate AI skills is seen as a major barrier to the pace of technological progress in the pharmaceutical market. 56% of senior AI professionals believe that a lack of additional, and qualified AI workers is the single most prominent hurdle to be overcome in terms of obtaining the necessary level of AI implementation beyond business operations. That is why a lack of skilled and experienced professionals may hamper the growth of Artificial intelligence in the pharma sector. The pharmaceutical industry needs a digital transformation on an urgent basis to analyze huge volumes of health data accurately and efficiently.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 19

20 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 21

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

ALKEM LABORATORIES

EXTENDING HEALTHCARE BEYOND BOUNDARIES

verything begins with an idea. Back in 1973, the idea of Alkem was born in the brilliant minds of a group of individuals. That idea when implemented led to the creation of one of India’s largest generic and specialty pharmaceutical companies which has now created a foothold in over 50 countries. Headquartered in Mumbai, Alkem Laboratories is a leading Indian pharmaceutical company that is engaged in the development, manufacturing, and sale of various nutraceutical and pharmaceutical products. It has its manufacturing facilities at multiple locations in India and the United States of America. Alkem Laboratories has a strong global presence in prominent countries like United States, Australia, Europe, Southeast Asia, Latin America, Africa, and CIS. Currently, its key markets are Australia, Chile, the Philippines, and Kazakhstan.

SANDEEP SINGH Managing Director

Sandeep Singh is the Managing Director of the company and spearheads the domestic as well as the international operations of the organization.

complex generics, topical, injectable, transdermal products, and oral liquids. It aims to introduce first-tomarket products of the best quality.

RESEARCH AND DEVELOPMENT

Alkem Laboratories has a team of more than 500 researchers, stationed at 6 different R&D centers located in India and the USA. The team works on developing generics, transdermal drug delivery systems, oral films, difficult-to-produce technology-intensive products, and Novel Drug Delivery Systems (NDDS). Some of its capabilities include:

Generics: This range includes oral solids, controlled substances,

22 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

Proprietary: Alkem offers a wide range of products spanning multiple therapeutic categories with a vigorous R&D strategy. Some of its brands have been featured among the top 300 brands in the Indian pharmaceutical market like Clavam, Pan 40, Pan-D, Xone XP, Taxim Injection, Gemcal, Ondem, Xone, A to Z Tabs,

Sumo, Zocef, Pipzo, Swich, Taxim-O, and Uprise D3.

Active Pharmaceutical Ingredients: The company ensures world-class active pharmaceutical ingredient (API) research, development, and manufacturing. It uses comprehensive process analytical and scaleup safety assessment procedures or tools.

Differentiated Products: Alkem Research Center focuses on the development of specialty and differentiated products like nasal sprays,

oral sprays, topical, transdermal patches, oral films, osmotic drug delivery systems, and MUPS. The Research Center of Alkem has successfully developed products and filled over 140 ANDAs (Abbreviated New Drug Applications) with USA FDA close to 60 products with TGA Australia.

MANUFACTURING FACILITIES

Alkem Laboratories also has its manufacturing units. Main manufacturing operations produce generics, branded generics, over-the-counter (OTC) products, Active Pharmaceutical Ingredients (APIs), and nutraceuticals. All these are available in a full range of dosage forms which include injectables, liquids, and capsules. For the production of best-in-class products, it also has state-of-the-art facilities that employ cutting-edge techniques of manufacturing.

MISSION OF THE COMPANY

Making “enriching lives‘ its only priority, Alkem Laboratories finds the best collaborative solution for the development and launch of each and every product. Making a difference in the lives of patients is the unwavering commitment that Alkem makes every day. The company works relentlessly towards the production of top-quality generic products, branded generics, specialty products, active pharmaceutical ingredients, and nutraceuticals, which are marketed in India as well as worldwide.

Anganwadi Centers into Modern Anganwadi Centers in Daman.

CORPORATE SOCIAL RESPONSIBILITY

Alkem Laboratories believes that good health is the right of every Indian, therefore it regularly holds medical camps as well as runs an ambulance service. It works in different fields: Public Health: The Alkem Foundation strives to increase access to good quality healthcare services to economically disadvantaged sections of the society. It organizes medical camps for Cancer detection, Eye Cataract, TB, and Anemia, promoting hygiene awareness and adolescent health with special emphasis on the girl child. Education: To support the economically weaker sections, of the society, it partners with various NGOs and runs classes for children living in slums in Dharavi, Mumbai, and tribal areas of West Bengal and Indore. It has also constructed and modified various

Rural Development: With an aim of creating employment and equal opportunities for disadvantaged women in rural areas, Alkem provides stitching training to women at Baddi and Naugama (Gujarat) and Daman. It also provides basic infrastructure facilities like toilets and hygiene drinking water to help villagers in improving their health and reducing the spread of water-borne diseases.

in Biotechnology & Pharmaceuticals in 2021 by Great Place to Work

Express Pharma Excellence Award at Pharma CXO Summit 2019

Rising Digital Star of The Year Award

With an adventurous and exciting journey of more than five decades, Alkem Laboratories has proudly earned the status of being one of the leading global pharmaceutical formulation development, manufacturing, and marketing companies of India.

Covid 19 Project: The company has supported the Government Health Department of Sikkim and Daman in the establishment of Covid-19 Testing and Diagnostic Lab in both states.

AWARDS AND MILESTONES

Alkem Laboratories has added many feathers to its cap. Some of the awards it has received so far are:

Best IT Team of The Year Award at “CIO Conclave and Awards 2020” organized by UBS Forums. Recognized as India’s Best Workplaces TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 23

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

ARCH PHARMALABS

SERVING SOCIETY THROUGH TRUSTED LIFESAVING PRODUCTS

The company currently captures values at 3 prominent parts of the CRAMS value chain through different initiatives:

any pharmaceutical companies are conducting extensive researches and are often credited for providing potential cures for lifesaving treatments. One such company is Arch Pharmalabs. It is one of the topmost pharmaceutical companies that is aligned across two business verticals-Products and Services. Its products business comprises manufacturing and sale of Active Pharmaceutical Ingredients and intermediates to innovator and generic pharmaceutical players in both domestic and international markets. To expand its horizons, the company has also evolved over the years and offers contract research and manufacturing services (CRAMS). Ajit Kamath is the Executive Chairman and Managing Director of the company. He is involved in the planning and formulation of the entire business strategy and developing long-term business relationships for Arch Pharmalabs.

FOCUS ON QUALITY AND SAFETY

Arch Pharmalabs continuously focuses on improving its Quality Management Systems and maintaining full compliance with all applicable statutory and regulatory requirements with an aim to achieve total customer satisfaction. The company has assigned certain responsibilities to the Corporate Quality Assurance Department. Some key responsibilities include:

Ensuring full compliance with cGMP, ICH Q7A, ISO, pharmacopoeial requirements that are clearly implemented by the staff of the company.

24 | TheGlobalHues | Vol. 1

AJIT KAMATH

Executive Chairman & MD

Establishing quality objectives and performance standards.

CONTRACT RESEARCH AND MANUFACTURING SERVICES

Arch Pharmalabs provides many CRAMS such as route selection/ process development/ optimization, analytical development, stability studies, safety studies, scale-up to technology transfer / clinical-trial manufacturing to commercial manufacturing to suit US / EU regulatory requirements. The company handles and manages various complex reactions at different scales of operation, ranging from a few grams to several tonnes. By using a proprietary bio-catalytic/ enzymatic technology availed by the company, it has developed an innovative route for the manufacturing of key advanced intermediates.

| Issue 15 | October 2021

Pre-Commercial Work includes exclusive synthesis/custom work for innovators on NCE candidates.

High-Value Technologies With Significant Entry Barriers includes manufacturing of technologically challenging products.

Commercial Manufacture Of On-Patent APIs And Intermediates includes partnering in drug development efforts through custom manufacturing of APIs and Intermediates and also participating in process research.

ENVIRONMENT, HEALTH & SAFETY

All the activities and services are carried out considering appropriate environmental, health, and safety risks. It works in accordance with the relevant legal requirements. It has incorporated certain EHS measures which include:

Full-fledged effluent treatment plants on all facilities

Solid Waste Management Systems

Solvent Recycling

Water Treatment Facilities

Arch Pharmalabs has also invested in reverse osmosis plants which is a proof of its commitment to exemplary EHS practices. Its treatment plants have both anaerobic and aerobic treatment facilities.

KEY TECHNOLOGIES OF THE COMPANY Diversified Offering Portfolio The company provides more than 120 products (over 65 APIs and over 55 Intermediates) across various therapeutic segments including side chains of Semi-Synthetic Isoxazole Penicillins under Antibiotics, Lipid-Lowering Agents, Oncology, Anti-Platelet Agents, Anti-Asthmatic, Anti-Retroviral, Decongestant, Anti-Herpes, Anti-Malarial, NSAIDs, Anti-Anginal segments. Over the years, it has also added services under CRAMS. Not only this, it has also increased its presence in therapeutic segments like Lipid-Lowering and Anti-Platelet Agents and has forayed into growth potential segments like Oncology and Controlled Substances. R&D and Key Technology tie-ups Over the years, the company has built itself in handling several complex reactions in a cost-effective manner ranging from multiple, multi-product facilities with capacities varying from gram to kilograms and multi tons. It has done technology agreements with many technology providers based in the US, UK, and

EU. These technologies further help the company to work towards the implementation of green Chemistry initiatives which not only help in reducing the production costs but also improving the quality of the products. R&D Capabilities Arch Pharmalabs has the best R&D capabilities for the identification and development of potential API and intermediate products and towards process development, analytical research, and clinical research. Its consistent focus on research and development has resulted in several patent applications with Indian, US, and European patent offices.

company to expand its product portfolio and product mix in response to changes in customer demand and to serve customer requirements ranging from laboratory scale research to commercial production. Currently, it has 8 manufacturing facilities across India with reactor capacities of around 1200 KL. Established in the year 1999, the company strives to maintain integrity during challenging situations. Its biggest growth is the result of being ready to face the toughest times and proudly emerging victorious. Arch Pharmalabs’ contribution to the pharmaceutical industry is phenomenal.

Manufacturing Facilities The company manufactures a variety of APIs and intermediates using a combination of processes. Its manufacturing infrastructure is very flexible that enables the TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 25

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

AUROBINDO PHARMA

COMMITTING A HEALTHIER & HAPPIER LIFE

orn out of a strong vision, Aurobindo Pharma was founded by P. V. Ramprasad Reddy and K. Nityananda Reddy in the year 1986. It has evolved and expanded over the years and has a strong presence in key therapeutic segments such as neurosciences (CNS), cardiovascular (CVS), anti-retroviral, anti-diabetics, gastroenterology, and Anti-biotics.

K. RAGUNATHAN Director & NonExecutive Chairman

Today, Aurobindo Pharma exports to over 150 countries worldwide. The company’s multiple facilities are approved by leading regulatory agencies like USFDA, EU GMP, UK MHRA, South Africa-MCC, Health Canada, WHO, and Brazil ANVISA. K. Ragunathan is the Independent Director and Non-Executive Chairman of the company. He has expertise in Management Consulting, Enterprise Software Processes, business transaction structuring, and capital market.

BUSINESS UNITS OF THE COMPANY Active Pharmaceutical Ingredients: Aurobindo Pharma is a top API supplier at the global level. It is present across beta-lactams and non-beta lactams which makes it one of the few players working in this field. In beta-lactams, it provides sterile and non-sterile penicillin and cephalosporins along with penams. All the API plants are equipped with particle size modifications systems to supply compacted and micronized materials.

26 | TheGlobalHues | Vol. 1

AuroZymes: It is the biocatalyst division of the company. The work of Autozymes is to develop and manufacture biocatalysts for use in the pharmaceutical and chemical industries. Autozymes are supported by a state-of-the-art R&D division in a 21 acres campus in Pashamylaram, Hyderabad. The company’s mission is to produce scalable biocatalytic solutions for use in the Pharmaceutical, Chemical, and Fine Chemical Industries, by reducing the cost of goods in processes, whilst benefitting from Green Technology.

| Issue 15 | October 2021

AuroSource: It is the Custom Research and Manufacturing division of the company. AuroSource offers the pharmaceutical industry across the globe, a new and fresh approach for the outsourcing of chemistry services with a devoted focus on enhancing value for the customers. AuroSource also offers comprehensive outsourcing options in registered starting materials, intermediates, and APIs. Auro Peptides: It is the subsidiary division of the company that delivers

innovative solutions from discovery to development and commercialization through cost-effective drug development and manufacturing. Auro Peptides deliver cGMP material in a timely, transparent, authentic manner and in a facilitative environment, through streamlined processes and a highly skilled workforce. Some of the peptide links are Desmopressin, Glatiramer, Leuprolide, Cetrorelix, Linaclotide, Bivalirudin, ACTH (1-39), Octreotide, Eptifibatide, Somatostatin, Teriparatide (HPTH 1-34), Goserelin, Vasopressin, and Buserelin. Formulations: Aurobindo Pharma has 15 state-of-the-art formulation manufacturing facilities located in India, Portugal, United States, and Brazil. All its facilities have received accreditations from reputed regulatory bodies.

RESEARCH AND DEVELOPMENT

Aurobindo is one of the largest R&D facilities in India. Its R&D team engages in the process of developing new drug delivery systems, new dosage formulations, and applying new technology for better processes. It currently has 5 research centers spread over 16,000 square meters. To ensure robust R&D, it employs over 1560 scientists and analysts in product development. This ensures a quick turnaround time in areas like: Project/product identification Literature evaluation / patent study API process development Formulation development Pilot BA / BE Exhibiting batches for dossier submission Stability studies for global requirements Aurobindo’s research center is capable of developing, scaling up, and commercializing various dosage forms spread across tablets, capsules, soft gels, oral liquids, injectables (solutions, suspensions, lyophilized, etc.), and ophthalmic (threepiece and BFS) and nasal delivery systems. The research center focuses on the areas of organic synthesis, analytical research, dosage form development, pharmacology, bioequivalence studies, and drug delivery systems. It facilitates:

Complete impurity profiling in all the products developed Development of analytical methods and specifications from raw materials, to non-compendial finished products

Company of the Year Award at the Global Generics & Biosimilars Awards 2019 The Platinum Certificate of Outstanding Exports Award from Pharmexcil in 2011

In-house synthesis of reagents for analyzing organolithiums and noble metals

The India star Award 2020 for Integrated Drug DeliverySystem from the Indian Institute of Packaging

Accelerated and real-time stability studies

A company that started its operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry, has now proudly evolved into a knowledge-driven company manufacturing APIs and formulation products. Aimed at delivering sustained growth, the company is diligently and sustainably achieving excellence and expertise in whatever innovation or experiment it does.

MISSION AND VISION

The mission of the company is to become the most valued pharmaceutical partner to the World Pharma fraternity by continuously researching, developing, and manufacturing a broad range of pharmaceutical products maintaining the highest regulatory standards. Its vision is to become a leading and an admired global pharma company, ranked in the top 25 by 2030”.

AWARDS AND MILESTONES

Over the years, Aurobindo Pharma has received many prestigious awards. Some of the coveted awards received include:

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 27

Shocking Fact About

We Bet You Didn’t Know

How Does Google Earn Money?

e have been using Google and its verified services for years and for free. Whether you want to get the latest news, learn a new language, or play games, it is all possible with just a few clicks without having to spend a single penny. While you continue to do so, does it never strike your mind- If we don’t pay Google, how does Google make money after all?

According to Google Earnings Report 2020

Alphabet had a net income of $40.26 billion

Google’s revenue increased by 12.7%

Google made $146.92 billion from advertising

Alphabet had total revenue of $56.89 billion in Q4 2020

According to Statista, the 2020 annual revenue of Google reached up to 181.69 billion US dollars. If you think that is insane, just know that these numbers go up every passing year. Google has numerous ways of generating revenue. Let’s dig deep into how the Google algorithm works and figure out how Google provides us with its best services and makes billions of revenue at the same time.

GOOGLE’S MAIN BUSINESS

Alphabet is one of the most valuable publicly traded businesses in the world, with a market valuation of nearly $1.5 trillion, trailing just Apple, Microsoft, and Amazon. Alphabet is effectively a holding company for Google, which accounts for nearly all of the business’s revenue and profit. Google has long positioned itself as a technological business, investing in a variety of cutting-edge fields such as internet search, mobile phones, artificial intelligence, self-driving cars, and health technologies. In fact, Google I/O aimed at software professionals, is known for mixing dense technical discussions with far-reaching ideas of the future. However, online advertising is Google’s major business.

28 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

GOOGLE ADS AND ADSENSE: BEHIND THE NUMBERS

Aside from private investment and stock sales, Google has a variety of revenue-generating alternatives. Google partners with merchants and advertisers in a number of ways, including Google Pay, Google Ads, Google AdSense, and Google Analytics.

ROLE OF GOOGLE ANALYTICS IN ADVERTISING

Google Analytics is a great tool for tracking website traffic and gaining a better understanding of who your users are and what they’re looking for on your site. Besides, it also provides an in-depth account of a business’s online performance. Data is an important cornerstone of any digital marketing strategy, and having the appropriate tools in place before you start marketing ensures you achieve the outcomes you desire. Google Analytics provides you with that and much more. Here are some of the other benefits that come from Google Analytics in digital marketing and advertising: The main way Google generates its revenue is through a pair of advertising services called Ads and AdSense. When you use Google to look for everything from financial information to the weather in your area, you’ll get a list of search results generated by Google’s algorithm. The algorithm tries to deliver the most relevant results for your query, and you may see similar suggested pages from a Google Ads advertiser alongside these results.

Offline to Online Tracking

Advertisers must outbid each other to get the top spot in Google advertisements. Higher bids rise to the top of the list, while low bids may go unnoticed.

Data Reports And Customization

Ads With the help of Advertising, advertisers submit ads to Google that comprise a list of keywords related to a product, service, or company. The ad shows in a sidebar on the SERP (Search Engine Result Page) when a Google user searches the Web using one or more of those keywords. When a user clicks on the ad and is directed to the advertiser’s website, the advertiser pays Google. For highly competitive target keywords such as insurance, loans, and other financial services, a click could be worth anything from a few cents to over $50.

Online Advertising With Marketing Analytics Improvement

AdSense Google’s AdSense program allows non-Google websites to embed Google display advertising on their pages in addition to search advertising. AdSense advertisements work in the same way as Google’s onsite ads, except they appear on Google-approved sites all over the Internet and a webmaster can choose to integrate ads on their site. The site’s content is thoroughly analyzed by Google’s spiders. Then Google picks advertisements with keywords that are related to the webmaster’s site. Google advertising can be customized in terms of type and location by webmasters. The site receives a share of the ad revenue every time someone clicks on an ad on the site and Google gets the rest.

Search Engine Optimization And Content Marketing Improvement

Google Analytics Conversion Tracking

Finding The Right Target Audience

Understanding the user Behavior

FINAL WORDS

One of the main channels of profit for Google has been Google Ads- the advertising feature that used to be called Google AdWords. And it makes sense because advertising on the world’s largest search engine platform is extremely important for any business. It ensures that a large number of people see what you’re trying to sell, and you can literally filter out the people who don’t want to view your ads based on a variety of parameters.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 29

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

CADILA PHARMACEUTICALS

ENSURING OPTIMUM HEALTH OUTCOMES FOR ALL

rom driving medical progress to improving the health and quality of life, pharmaceutical companies are contributing a lot to the society. One such company is Cadila Pharmaceuticals. Committed to universal health and wellness, Cadila Pharmaceuticals is a well-known Indian multinational pharmaceutical company. It develops, manufactures, and markets innovative and affordable medical and health solutions. Being one of India’s largest privately held pharma companies, the company is dedicated to achieving continuous excellence in pharmaceuticals and life sciences. In the last 70 years, it has established a strong presence throughout the pharmaceutical value chain from research & development (R&D), manufacturing, packaging, marketing, and distribution, both at the domestic and international levels. Cadila Pharma is a fast-progressing Life Sciences enterprise and a significant leader in global health with quality and affordability at its core. Its core values are Care, Quality & Affordability, Legacy, and Innovation. Cadila has made several leaps and strides to become a formidable player in global health under the visionary leadership of Dr. Rajiv Modi. He is the Chairman and Managing Director of the company. He is a biotechnologist and has a rich experience in managing pharmaceutical business. With a strong vision to revolutionize the life sciences industry, he has played a crucial role in establishing research, manufacturing, sales, and distribution for Cadila Pharmaceuticals across the world.

30 | TheGlobalHues | Vol. 1

DR. RAJIV MODI Chairman & MD

RESEARCH AND DEVELOPMENT

Science and innovation produce the perfect synergy to produce life-enabling and lifesaving drugs and medicines for the whole world. They help the pharma industry come up with breakthrough ideas for addressing patient needs. Cadila Pharmaceuticals takes immense pride in the strong intellectual capital and years of experience it brings to Chemistry, analytical techniques, dosage forms, new formulations, preclinical research, clinical research, and many more areas of science.

| Issue 15 | October 2021

It has successfully introduced novel, and first-in-the-world innovations such as Mycidac C (immunotherapy in lung cancer), Polycap (polypill for cardiovascular disease prevention), Risorine (bio-enhanced Rifampicin for TB therapy), and Rabeloc IV (Rabeprazole in IV form). Cadila Pharmaceuticals is also known for quality manufacturing in biosimilars and vaccines like the world‘s first nanoparticle-based vaccine for influenza - Cadiflu-S and the world’s first three dosage

recombinant nano-particle-based Rabies vaccine, ThRabis, The company’s innovative drug, Sepsivac as an immunomodulator in sepsis, was found to boost the innate immune response and increase resistance against the progress of COVID-19. Sespsivac offered 11% absolute reduction and a 55.5% relative reduction in mortality in patients of gram negative sepsis.

RESEARCH AREAS

Cadila Pharmaceuticals has a dedicated R&D department comprising 300 scientists. They work in different research areas: Formulation Development Herbal Product Development API solutions Pre-Clinical and Clinical Research Biotechnology

ACTIVE PHARMACEUTICAL INGREDIENTS

Cadila Pharmaceuticals is one of the top Active Pharmaceutical Ingredient manufacturing companies in the world. Spread over 80,000 sq. meter area, it is globally accredited by US FDA, Health Canada, PMDA Japan, TGA Australia, COFEPRIS Mexico, KFD Korea, ANVISA Brazil, etc. The API manufacturing facility is located in Ankleshwar, Gujarat. Currently, the company offers 38 APIs and intermediates across various therapeutic categories – respiratory, diabetology, gastroenterology, pain management (antimigraine), orthopedics, and many more. It is confident of building an unmatched API portfolio in the entire globe.

BIGGEST CHALLENGE FACED BY THE COMPANY

The Covid-19 pandemic was by far the biggest challenge for the company. However, it gives the company tremendous pride to state that although initially the business was hit, but it soon came back on its track. Cadila attributes this success to its tireless workforce who showed great courage and determination to ensure that the health of countless people all over the world did not suffer setbacks. Staying true to its motto of ‘The Care Continues…’ all the employees put in their hard work and dedication day and night to overcome all the challenges posed by the pandemic.

VISION AND MISSION OF THE COMPANY

The vision of Cadila Pharmaceuticals is to become a significant global player by providing high-quality, affordable, and

innovative solutions in medicine and treatment. The mission is to discover, develop and successfully market top-quality pharmaceutical products to prevent, diagnose, alleviate and cure diseases.

excellence in the pharma industry. Some of them are:

DEFINITION OF SUCCESS

Observe Now Future of Workplace Award 2019

“Success comes when one has achieved the goals but more importantly made the right impact. For example, when we develop a drug, we do it with the intention to make life better for people. We have attained success in several endeavors. However, we continue to set new and more ambitious goals and strive to be successful in achieving those as well. Success for us is an ongoing process, it never stops.” says Dr. Rajiv Modi, the Chairman and Managing Director of the company.

AWARDS AND MILESTONES

Cadila Pharmaceuticals has won many prestigious awards for its efforts and

TISS LeapVault Award 2019 Worldstar Packaging Award 2019 Future Warehouse Award 2019

Brand Leadership Award 2019 by CMO ASIA. Best Employer Brand Award 2019 Times CSR Awards 2021 Cadila Pharmaceuticals has become a leading pharmaceutical company today and is catering to the healthcare needs of over 85 countries worldwide. Committed to complying with the highest ethical standard in clinical research and medical practice, it is now popularly known as a care-focused, and research-driven company across the globe.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 31

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

DIVI’S LABORATORIES

ENSURING UNINTERRUPTED SUPPLY OF HIGH-QUALITY APIs

ounded in the year 1990, Divi’s Laboratories is among the top pharmaceutical companies that has recently reached the milestone of being one of the top 3 API manufacturers in the world. It is the leading manufacturer of APIs, intermediates, and registered starting materials offering high-quality products with the highest level of compliance and integrity to over 95 countries.

DR. MURALI K. DIVI Founder & MD

With an aim to bring world-class products to customers, Divi’s consists of 17000 highly trained professionals and 500 scientists. Dr. Murali K. Divi is the Founder and Managing Director of the company. He oversees and manages the overall technical and financial operations of Divi’s.

BUSINESS SEGMENTS

Divi’s manufactures general API, nutraceutical ingredients, and custom synthesis for big pharma. Since the inception of the company, various diverse teams of Divi’s have been involved in providing highquality Generic APIs, Custom Manufacturing solutions to several Big Pharma. It has most recently started providing highly specialized Nutraceutical ingredients as well and has now become one of the selected nutraceutical ingredients manufacturers offering a complete range of carotenoids at a very competitive offering for food, feed, and dietary supplements worldwide. Its three main business segments are: Generic APIs Committed to emerging as a reliable supplier in APIs, it continuously improves

32 | TheGlobalHues | Vol. 1

the process and engineering efficiencies and implanting various green Chemistry principles. It currently manufactures 30 APIs commercially while 10 APIs are in various stages of the R&D/pilot scale development process. Custom Synthesis The company is engaged in Custom Synthesis (contract manufacturing services) of APIs and Intermediates for global innovator companies with an extensive portfolio of products across different key therapeutic areas.

| Issue 15 | October 2021

Nutraceuticals Divi’s has nutraceutical facility that produces active ingredients and finished forms of Carotenoids. The company currently supplies most of the carotenoids to all the major food, dietary supplement, and feed manufacturers around the globe. Some of the leading products are Beta Carotene, Lutein, Astaxanthin, Lycopene, Vitamin D3, and Vitamin A.

RESEARCH AND DEVELOPMENT

Divi’s has 3 R&D Centers, 500 scientists, 39 process patents, and 6 new generics. All

highly trained and professional scientists at Divi’s are engaged in developing non-infringing processes attaining commercially viable prices throughout the lifecycle of any product, infiltrating continuous process improvements. It also has Process Development Centers that work on developing environment-friendly processes and allows easy and efficient scaleup.

MANUFACTURING FACILITIES

Divi’s currently operates two manufacturing sites near two states in India, Hyderabad, and Visakhapatnam. Both the units have more than fifty production buildings and sixty pharma suites with a total reaction capacity of more than 14000m³ that makes it one of the largest API manufacturing facilities in the world. It is also the commercial-scale manufacturer of non-potent & highly potent APIs to deliver from gram scale to 1000’s of tons under cGMP ( Current Good Manufacturing Practices).

CORPORATE SOCIAL RESPONSIBILITY

As goodness is the only investment that never fails, Divi’s focuses on an integrated business model with social and environmental priorities and organizes various corporate social responsibility programs. Through its CSR activities: 15000 children have been benefited from child empowerment programs 215,000 people have been provided with safe drinking water 135,000 saplings have been planted under various plantation drives 80,000 people have been benefited from village development programs

ENVIRONMENT, HEALTH, AND SAFETY

Divi’s commits to monitor and take several safety measures, promote a healthy environment for all staff to create a highly productive environment for all. The company has taken up various activities under this initiative which include green belt development, water, energy, and waste management, and reduction in carbon footprint.

MISSION AND VISION OF THE COMPANY

The mission of the company is to become a responsible business that adds value in the area of Chemistry along with serving the immediate community and at large through its diverse social initiatives that would establish a strong foundation for a better tomorrow for all stakeholders. Divi’s

Laboratories envisions to create value for all stakeholders by manufacturing highquality Generic APIs, Custom-synthesis of APIs & Intermediates along with Nutraceutical Ingredients to the Global Pharmaceutical & Nutraceutical industry through sustainable leadership in Chemistry.

May Day Award for Best Management by Department of Labour, Government of Andhra Pradesh in 2013

AWARDS AND MILESTONES

Best Green Belt Development Award by Government of Forests Nalgonda in 2011

Divi’s Laboratories’ contribution to the pharmaceutical sector is admirable. It has received many awards because of its excellent work in the industry. Some of them are: Occupational Health and Safety Management System Award by Bureau Veritas Quality International in 2018

Indian Business Leader Award ”First Generation Entrepreneur of the Year” by CNBC TV 18 in 2012

Widely recognized for its manufacturing of APIs and other high-quality products, Divi’s has been contributing a lot to the pharmaceutical sector for the last 30 years.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 33

10 MOST VALUABLE

PHARMACEUTICAL

INDOCO REMEDIES COMPANIES IN INDIA

UPGRADING HEALTHCARE ACCESS WITH QUALITY MEDICINES

week after India’s independence, a company took birth with the intent to manufacture and sell pharmaceutical formulations. Founded by Late Govind Ramnath Kare, on 23rd August 1947, Indoco is a fully integrated and research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). It has more than seven decades of presence in the market and is strengthening its wings in the international markets by offering complete solutions, including product development, manufacturing, and supply of finished medicines, APIs, and Intermediates to generic companies across the globe. Inodoco has a total of 9 manufacturing facilities out of which 6 are for finished dosages and 3 for APIs. Around 6000 personnel including over 300 skilled scientists work in the company. Indoco is achieving consistent growth due to its expertise in R&D activities, backward integration in API in select products, and excellence in dosage manufacturing. The Managing Director of the company is Aditi Kare Panandikar. She has received the ‘Leader of The Year’ award at the Business Goa Awards for Corporate Excellence 2016. Her outstanding and high-powered leadership has played a major role in taking the company to greater heights.

BUSINESS UNITS OF THE COMPANY

Active Pharmaceutical Ingredients (APIs): Indoco offers a wide range of services with respect to API supplies.

34 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

ADITI KARE PANANDIKAR

Managing Director

All the new APIs are developed through non-infringing processes, which leads to the hassle-free launch of high-quality products. Its API manufacturing facility is located in Patalganga. A pharma zone is also designed to maintain class 100 thousand conditions with proper pressure differentiation of filtered air through the HVAC system. It also has a purified water system having a DM plant with an RO system. It offers its R&D capabilities to innovators and generic

companies for APIs and Intermediates development. The services offered include Custom Synthesis of Molecules and Intermediates, and Non – Infringing Process Designing and Scale-up. To manufacture APIs and intermediates, Indoco has stateof-the-art facilities. It also manufactures and exports APIs and intermediates to Regulated and Emerging markets with necessary documentary and plant approval support.

Finished Dosage Forms: Indoco offers many dossier development services. Dosages offered include Solid Dosages, Creams & Ointments, Toothpaste, Liquid Orals, Ophthalmics, and Injectables. It exports its products to many countries like Congo, Ethiopia, Algeria, Iraq, Malaysia, Mauritius, Philippines, Sri Lanka, Swaziland, Tanzania, Thailand, UAE, Zimbabwe, and many more.

RESEARCH AND DEVELOPMENT

Spread over an area of 100,000 sq. ft., the facilities at the Center include Synthetic Chemistry Labs, Formulation Development, Analytical Method Development, Regulatory and Intellectual Property Rights Cell. The company’s API section has the capabilities to not only synthesize APIs and work on process development but also on the development of non-infringing processes for APIs and intermediates. The research and Development team engages in the development of different kinds of dosage forms like solid & liquid orals, creams & ointments, ophthalmic preparations, small volume parenteral, and dental products. Not only this but it also engages in the areas of modified release products like controlled release and sustained-release products.

VISION AND MISSION OF THE COMPANY

The vision of Indoco is to improve and enhance the quality of life by making available high-quality products at economical rates. It also aims to become a researchbased globally known company present in all continents of the world. The mission of the company is to continue to be quality-driven, research-based, and a focused pharmaceutical company in the market and build on the trust generated by the medical fraternity.

CORPORATE SOCIAL RESPONSIBILITY

The company is committed to its social responsibility and performs many CSR activities.

Sumati Sangopan: Indoco gives financial and non-financial support by working with institutions engaged in CSR activities across India. It works in the areas of education, health, environment, and sanitation and strives to make a positive contribution to society by lending a helping hand to the needy sections.

Suresh Kare Indoco Foundation: As the company believes in healing several lives and creating a brighter future, the foundation sponsors the scholarships of needy students. It also works with NGOs and sponsors various social and cultural events.

AWARDS AND MILESTONES

Indoco has bagged many prestigious awards and recognitions. Some of the prominent ones include:

The IDMA Formulations Best Patent Award 2018-19 for 2 formulation patents – Diclofenac & Quetiapine

The IDMA Formulations Patent Award 2017-18 for 1 International and 2 Indian patents – Olopatadine, Gliclazide & Brinzolamide Ophthalmic Solution

The ‘Best Patent Award’ by PHARMEXCIL in the Bulk Drugs / API category in 2016

‘Patent Appreciation Award’ at 52nd IDMA Award Function in 2014

During the pandemic, Indoco used several different approaches and provided immediate assistance to all the doctors by distributing PPE kits, sanitizers, masks, and educating patients about safety precautions. Indoco’s response to the Covid-19 pandemic was fast and furious. It is undoubtedly improving the quality of life of many people across the globe.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 35

36 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 37

COWORKING SPACES A NEW NORMAL POST COVID-19

According to reports, there are about 35,000 flexible workspaces in the world today. Its global market value is estimated at approximately $26 billion.

rom a whisper to a scream best illustrates the sudden expansion of coworking spaces in the post covid world. Although the concept of coworking spaces is not new to the world but the advent of the pandemic has solidified coworking’s standing as a preferred workplace solution. A new generation of entrepreneurs brought with it a critical eye on the traditional office system. In the 90s, the demand for coworking space grew due to the strong desire for flexibility, and a longing for community. EVOLUTION OF THE TERM The first usage of the term “Coworking” dates back to 2005 when Brad Neuberg, a frustrated freelance computer programmer launched the first coworking space in San Francisco. The place was named “San Francisco Coworking Space” and was opened on Mondays and Tuesdays. As the term

38 | TheGlobalHues | Vol. 1

was completely new to people, it didn’t attract any visitors in the first month of its establishment. In the early days, nobody knew the importance of coworking space and simply argued that it was nothing more than a movement that would fade away eventually but the current situation is leading to the expansion of this terminology. Today, many people use coworking spaces and workplace-as-aservice to refer to the same thing. One thing that becomes clear here is that no matter what terms anyone uses but flexible work environments are evolving very rapidly and are here to stay. WHAT DO STATISTICS SUGGEST? Despite the negative impact of Covid-19 on coworking spaces, it is expected to grow and thrive in the coming years at a fast pace. Despite the pandemic, many markets globally have shown increased demand for flexible

| Issue 15 | October 2021

workspace, and on shorter terms. The Instant Group forecasts flexible workspace supply growth of over 21% in 2021. As of Q2 2020, the coworking footprint nearly doubled since 2017 to 86.0 million square feet. Coworking space as a percentage of total office space nearly doubled from 1.1% in 2017 to 2.1% as of Q2 2020 Coworking is not just liked by corporates but it is also grasping the interest of landlords, property developers, and investors. According to research and surveys, landlords will increasingly allocate 10 – 25% of their assets for flexible leases. The share of the flexible office market held by London continues to grow year on year, up to 31% in 2020.

The UK flexible workspace market is on track to hit 12.5% penetration within two years – a doubling of current supply. Inner cities have become the most popular location type to date in 2020 with a 52% share of demand. Coworking Insights surveyed 360 individuals in partnership with Coworker. The respondents were asked to rate remote working on a scale of one to 100. The respondents rated remote work a 70 out of 100 on an average. COMPANIES THAT EXPERIMENTED WITH THE CONCEPT OF COWORKING There are many well-known and famous companies that started at coworking spaces. Some of them are: 1. UBER: The founders of Uber Travis Kalanick and Garrett Camp started to solve the cab crisis in San Francisco at a coworking space. Now, Uber is currently operating in over 85 countries around the globe and the number continues to grow each passing year. 2. INSTAGRAM: Kevin Systrom and Mike Krieger founded the now-famous social networking application at Dogpatch Labs coworking space. Today, Instagram has 1 billion monthly active users at the global level.

3. SPOTIFY: It was launched in 2008 by Daniel Ek and Martin Lorentzon in a coworking space based in Stockholm, Sweden. Spotify recently reported a rise in total monthly active users by 22%. It had 165 million premium subscribers worldwide, as of the second quarter of 2021. 4. HOOTSUITE: It was also launched at a coworking space in San Francisco by Ryan Holmes in 2008. It continues to use coworking spaces around the globe while expanding. WHY COWORKING SPACES ARE IN DEMAND NOWADAYS? Nowadays, entrepreneurs are choosing coworking spaces thereby creating a lot of demand. There can be plenty of reasons: Increased Productivity: For business owners, it becomes difficult to concentrate on work when children need attention, and the house needs maintenance, etc. A coworking space, therefore, solves this problem. A coworking space not only helps you to immerse yourself in a perfect business environment but also helps you to cope with your tasks much faster.

better flexibility. If they like the experience, they can continue working otherwise there’s no harm in canceling the subscription. Cost-Efficiency: There are a lot of extra costs involved when you rent an office on your own, with extra added costs like furniture, internet, free coffees, and snacks, etc. However, flexible workplaces come equipped with an array of all these perks. Summing up, it can be said that coworking spaces are just not a trend anymore but are becoming the expected and preferred workplace of today’s workforce. Coworking spaces are now becoming mainstream. Companies are shifting towards more flexible workforces without creating the hassle of paying hefty rents and other associated expenses for a long period of time, to counter the uncertainty of the future.

Sources: Statistics used in this report have been taken from various sources like The Instant Group, Coworking Insights, JLL, CBRE, Colliers International, and Cushman & Wakefield.

Flexibility: Coworking space providers always give flexible conditions that are comforting to any employer. No lease and term contracts ensure TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 39

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

IPCA LABORATORIES

STRENGTHENING GLOBAL HEALTHCARE

perating in the pharmaceutical sector is not an easy job. It involves a lot of responsibilities, integrity, and dignity to thrive as a pharma company. Ipca is a consumer-led global pharmaceutical company that is creating healthy doses since 1949 and following all the core values needed to survive in the pharmaceutical sector. The company manufactures over 350 formulations and 80 APIs for different therapeutic segments. Today, it has become one of the world’s largest manufacturers and suppliers of APIs. At Ipca, All the APIs are manufactured from scratch at fully automated manufacturing facilities and are approved by the world’s leading regulatory authorities like UK-MHRA, EDQM-Europe, WHO-Geneva, and many more. Premchand Godha is the Chairman and Managing Director of the company. Under his supervision, the company has achieved massive success and has proudly brought Ipca to the forefront of the Pharmaceutical market.

BUSINESS UNITS OF THE COMPANY

Active Pharmaceutical Ingredients (APIs) The company produces 80 APIs at 12 production facilities. Its focus has always been on backward integration, resulting in superior supply chain reliability and cost competitiveness in the market. Its manufacturing leadership extends across Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic),

40 | TheGlobalHues | Vol. 1

PREMCHAND GODHA Chairman & MD

Hydroxychloroquine Sulphate (DMARD), Losartan (anti-hypertensive), Metoprolol Succinate (anti-hypertensive), Metoprolol Tartrate (anti-hypertensive), Pyrantel Salts (anthelmintic), and Propranolol (anti-hypertensive). Branded Formulations-India Ipca manufactures more than 350 formulations in almost every dosage form. Its 4 branded formulations are ranked amongst the top 300 brands of the Indian Pharma Market as per IQVIA’s May 2020 report. Ipca is present in every corner of

| Issue 15 | October 2021

India with 25 depots and 3200 stockists across the country. Its finished formulations can be found at over 5,00,000 retail shops in India. Branded Formulations-International Ipca markets its branded generics to the Rest of the World (ROW) market. It has a workforce of around 900 employees in around 40 countries across various geographies like East, and West Africa, South East Asia, the CIS, Latin & Central America. Ipca’s ROW product basket includes around 75 brands spanning many

therapeutic categories like Nutritional supplements, Cardiovascular, Diabetes, CNS, Pain management & Arthritis, Anti-infectives, Anthelmintics, Gastroenterology, Ophthalmic, etc. Generic Formulations Ipca offers a diverse product portfolio that caters to major therapeutic segments in virtually every dosage form- Oral liquids, Powder for suspension, and Small volume injections (dry & liquid). To compete with the growing generic arena, it has fortified its capabilities in terms of infrastructure by establishing 4 manufacturing facilities catering to regulated markets.

RESEARCH AND DEVELOPMENT

1. Chemical & Biotechnological Research and Development. Over the past few years, Ipca has been focusing on conducting research and development of path-breaking products. The focus of the R&D team is to produce inventive concepts and ideas, tapping both market needs and synergies across therapeutic domains. Major activities and expertise of this division include: Chemical Research: It includes new and alternative cost-effective process routes, non-infringing processes, process engineering, impurity and standards synthesis, green Chemistry, Novel polymorphs/derivatives, Productivity enhancement through a continuous batch, and increasing plant friendliness. Analytical Research: It includes method development, impurity profiling of APIs, method validation, and regulatory compliance meeting global standards. Bioprocessing and metabolic engineering: The focus of this unit is to develop a strong pipeline of fermentation products to reduce dependency on imports. New Drug Discovery and Development: It includes discovering New Chemical Entities, Drug repurposing, and improvements, and collaborating with international research organizations. One of the novel molecules (AT-10) produced has shown very promising antiplatelet activity and is currently in clinical Phase-I trial in the USA and India. 2. Formulation Development To conduct high-quality research activities and prototype development, Ipca has its

Formulation Development Laboratory in Mumbai. Some formulation R&D capabilities include design and development of new dosage forms, pre-formulation studies, process optimization/validation studies, technology transfer of new products, lab/pilot-scale studies, stability studies as per ICH guidance, technical supports to manufacturing location, technology, and latest development up-gradation to provide technically superior, process efficient and International standards product.

AWARDS AND RECOGNITIONS

CORPORATE SOCIAL RESPONSIBILITY

Working on the core values of quality, safety, integrity, dignity, and responsibility, Ipca has been advancing global healthcare for more than 65 years. With a presence in 120+ countries and 350+ formulations, Ipca is emerging as a leading pharmaceutical company.

With the belief that everyone deserves a healthy dose of life, Ipca engages in various CSR activities. It works in the areas of patient health, employee and public safety, nurturing the environment, and building sustainable communities. It has also established a charitable trust Prabhat Foundation to improve the lives of the underprivileged and contribute towards the betterment of the society.

Because of its research expertise, the company has bagged a lot of admiration in the pharma industry. Some of the awards it has received are: CPhI Pharma Excellence Award – Madrid, 2018 Best patent award from Pharmexcil in the years 2008, 2009, 2010, 2012, 2013, and 2014 Best patent award from IDMA in the years 2008, 2009, 2014, and 2016

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 41

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

SUN PHARMA

EXCELLING IN DEVELOPING GENERICS AND TECHNOLOGY COMPLEX PRODUCTS

cience is the heart of the Sun. With that belief in mind, a company emerged in the year 1983 which has now become the fourth largest specialty generic pharmaceutical company in the world. Sun Pharma is a leading pharmaceutical company that provides high-quality, and affordable medicines to more than 100 countries worldwide. The company manufactures and markets many pharmaceutical formulations covering a broad spectrum of acute and chronic therapies, which includes generics, specialty, over-thecounter (OTC), antiretrovirals (ARVs), complex or difficult to make technology-intensive products, branded generics, Active Pharmaceutical Ingredients (APIs) and Intermediates. Covering neuro-psychiatry, cardiology, gastroenterology, anti-infectives, diabetology, oncology, ophthalmology, dermatology, urology, and nephrology, it sells over 30 billion doses every year. Sun Pharma has its presence in over 80 markets, out of which prominent emerging markets include Romania, Mexico, South Africa, Russia, and Brazil. Dilip Shanghvi is the Founder and Managing Director of the company. He has extensive industrial experience in the pharmaceutical industry and has received many prestigious awards and recognitions for his valuable contribution to the pharmaceutical sector.

PRODUCTS

The product portfolio of the company is very comprehensive, diverse, and highly complementary. Its products range includes:

42 | TheGlobalHues | Vol. 1

DILIP SHANGHVI Founder & MD

1. Specialty Medications Over the years, Sun Pharma has built a strong portfolio of patent-protected specialty medicines. The key segments targetted by the company include dermatology, ophthalmology, and oncology. Its initiatives in this segment cover the entire value chain, right from in-licensing earlyto-late stage clinical candidates, to getting access to on-market patented products. 2. Generic Medications To build the trust of both patients and healthcare professionals, all the

| Issue 15 | October 2021

products have the hallmark of technology-based differentiation and cover the full range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The therapeutic segments covered in this portfolio of over 2000 molecules include psychiatry, anti-infectives, neurology, cardiology, orthopedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental, and Nutritionals.

3. Over-the-Counter Medications This range includes some of its well-known and famous medications like Faringosept (sore throat), Revital (vitamins), and Volini (topical analgesics). There are other category-defining brands too like Coldact & Flustat (cold & flu), Brustan, Painamol & Paduden (analgesics), Aspenter, Aspacardin, Nudrate & Fortifikat (lifestyle OTCs), Gestid (digestives), and Chericof (cough). 4. Active Pharmaceutical Ingredients As the company believes that APIs are a vital input in the manufacturing of complex formulations to facilitate vertical integration, it started producing APIs in 1995. Currently, the company manufactures APIs in 14 different manufacturing facilities located in India, Hungary, Israel, the US, and Australia. Its product list includes generics and complex APIs like anti-cancers, peptides, steroids, sex hormones, and controlled substances, including poppy-derived opiate raw materials and, are produced in isolated manufacturing areas. 5. Anti Retro Viral Medications Intending to improve access and affordability, it offers a broad range of WHO prequalified ARV medicines. It also contributes to combating HIV/AIDS through its several first-line and second-line Highly Active Antiretroviral Therapy (HAART) regimens.

CORPORATE SOCIAL RESPONSIBILITY

The company believes that business and responsibility go hand in hand. Therefore, it conducts various CSR activities. Priority areas include health, education, drinking water, and sanitation. Malaria Elimination: Its Malaria Elimination Demonstration Project aims to eliminate Malaria from 1233 villages of the Mandla district. Mobile Healthcare Units: This initiative aims at delivering primary healthcare services to over 6,50,000 people located around areas close to the company’s manufacturing plants and other establishments.

Sun Pharma Science Foundation: It encourages and rewards excellence in the medical and pharmaceutical sciences. It is an independent non-profit organization that promotes scientific endeavors in India.

CORE VALUES AND VISION

The company’s vision is to reach people and touch lives globally as a leading

provider of valued medicines. It follows certain core values that represent its promise to all the stakeholders. These are maintaining quality, consistency, and reliability, building trust, and discovering and implementing new ideas. It endeavors to bring new and valuable products to the market and consistently deliver value to all the stakeholders.

AWARDS AND MILESTONES

Sun Pharma has been awarded many prestigious awards. Some of them are: The Golden Peacock Award for Corporate Social Responsibility, 2020 The DIANA (Distribution Industry Award for Notable Achievements in Healthcare) award for ‘Best New Product Introduction/Promotion’ at the Annual Healthcare Distribution Alliance Conference 2021

India Pharma Research Development Award 2015 from the Ministry of Chemicals & Fertilizers, Government of India NDTV Profit’s Business Leadership of the Year Pharmaceutical Award in 2012 All the scientists working in the company deliver high-quality products. Currently, the company has 2000 highly trained scientists who work in six research centers across India, Israel, and the US. Pioneering in delivery systems of ophthalmology, cardiology, peptides, CNS, and oncology, Sun Pharma is one of the valuable pharmaceutical companies in India.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 43

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA

ZYDUS CADILA

BRINGING INNOVATIVE PHARMACEUTICAL SOLUTIONS TO LIFE

ver the years, the pharmaceutical industry is saving lives through effective drug manufacturing. It has been successful in bringing innovative therapies that help patients to live longer. Zydus Cadila, a leading company in the pharmaceutical sector is a fully integrated, and global healthcare provider. It is known for its in-depth expertise in the field of healthcare and the pharmaceutical value chain. Zydus provides comprehensive and complete healthcare solutions ranging from active pharmaceutical ingredients and animal healthcare products to wellness products. Originated in the year 1952 by Ramanbhai B Patel in Ahmedabad, Gujarat, Zydus continuously innovates with an unfaltering focus to address the unmet needs of the healthcare sector. Sharvil Patel is the Joint Managing Director of the company. Sharvil is a third-generation scientist and entrepreneur and has contributed a lot to the success of the company. Zydus never forgets and rededicates itself each day to its mission of creating a healthier, and happier communities across the world.

SHARVIL PATEL Managing Director

Driven by a passion for innovation, Zydus’s innovative program is spearheaded by 1400 researchers across 19 sites. Its major areas of research are:

significant drugs in demand-Lipaglyn, to treat diabetic dyslipidemia. This drug is the first chemical entity that moved from an Indian research lab to the market. This discovery has helped 700,000 patients suffering from diabetic dyslipidemia in India lead healthier lives.

1. NCE Research The team at Zydus conducts drug discovery & development from concept to IND enabling preclinical and clinical studies. In 2013, Zydus was the first to identify develop and launch one of the

2. Biologics Under biologics research, Zydus has made the world’s first biosimilar of Adalimumab-Exemptia. This drug provides a new lease of life to Indian patients with inflammatory arthritis. Another

MAJOR RESEARCH AREAS

44 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

significant discovery under biologics is Twinrab, the world’s first novel cocktail of rabies monoclonal antibodies (mAbs). It contains Docaravimab and Miromavimab that provide dual protection against rabies. 3. Vaccines Zydus has a dedicated Vaccine Technology Centre that has two state-of-the-art R&D centers, one located in Catania, Italy, and the other in Ahmedabad, in the western part of India. The center is developing vaccines for various vaccine programs

like Diphtheria, Tetanus, Haemophilus Influenzae type B, Influenza, Hepatitis B, Measles, Mumps, Rubella, Varicella, Pertussis, and Typhoid fever. Zydus is also credited for developing and manufacturing India’s first Tetravalent Inactivated Influenza vaccine, VaxiFlu – 4. It provides protection from the four influenza viruses- H1N1, H3N2, Type B (Brisbane), and Type B (Phuket).

ZYDUS ANIMAL HEALTH

Zydus Animal Health is India’s leading animal healthcare provider. It leads in many therapeutic segments like anti-bacterial, NSAIDs, Anti-mastitis, tonics, and poultry vaccines amongst others in India. To cater to the increasing demands of the pet community, the division has also launched a basket of products specifically for companion animals.

MANUFACTURING CAPABILITIES

Zydus group also has manufacturing capabilities including formulations, APIs, vaccines, biosimilars, complex products (transdermals, and topical, etc.), animal health products, and wellness products with more than 30 manufacturing plants across the world including India, Germany, Brazil & USA. Some of the prominent state-of-the-art plants include Finished Dosage Form in Moraiya, Baddi, Brazil and Goa, Formulations plant in Sikkim, Biologicals Active Substances in Ahmedabad, Topical Formulation Manufacturing, Vaccine Technology Center, and Alidac pharmaceuticals limited in Ahmedabad.

CSR PROGRAMMES

With the purpose of reaching out to the community and finding new expressions for its mission to create a happier and healthier community, it is dedicated to all dimensions and areas of health. 1. Swasthya: Health, Safety & Environment Under this program, Zydus organizes rural health awareness camps, deaddiction camps, and personal hygiene campaigns, and promotes preventive health care. It also focuses on Sanitation – making available safe drinking water. It ensures environmental sustainability through the maintenance of soil, air, and water. 2. Shiksha: Education Zydus gives support to the Zydus School for Excellence, organizes educational programs for farmers in the rural areas around its manufacturing facilities, gives

infrastructure support to primary schools, and also gives awards and recognition for school children in the rural areas around its manufacturing facilities. 3. Shodh: Research The company promotes research in pharmaceuticals and healthcare through the biennial symposium, The Ramanbhai Foundation International, a global knowledge-sharing forum on innovation.

MISSION AND VISION OF THE COMPANY

The mission of Zydus Cadila is to create healthier communities. The world of Zydus is shaped by a passion for innovation, commitment to partners, and concern for people in an effort to create happier and healthier communities globally. The company’s vision is to open new pathways through innovation and quality excellence.

The Overall India Pharma Excellence Award and the India Pharma Innovation of the Year Award from the Department of Pharmaceuticals, Government of India. The CII Industrial Innovation Grand Jury Award of being the Most Innovative Company of the Year. Declared the most Innovative Pharmaceutical Company by Thomson Reuters. Declared as the ‘Emerging Company of the Year’ by the Economic Times Awards for Corporate Excellence 2010. At present, its manufacturing sites and research facilities are spread across Sikkim, Maharashtra, Himachal Pradesh, Goa, and the five states of Gujarat. At the global level, Zydus has a strong presence in regulated markets of the United States, Europe (France & Spain), Latin America, and South Africa.

AWARDS AND MILESTONES

Zydus Cadila has received many awards so far. Some of the prominent awards are: TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 45

INTELLECT QUOTES ON

OPPORTUNITY “Each problem has hidden in it an opportunity so powerful that it literally dwarfs the problem.” -Joseph Sugarman “Success in life hinges more on seizing opportunity than having everything go according to plan. ” -Ethan Austin “Opportunity doesn’t make appointments, you have to be ready when it arrives.” -Tim Fargo “Opportunity is missed by most people because it is dressed in overalls and looks like work.” -Thomas Edison “A pessimist sees the difficulty in every opportunity; an optimist sees the opportunity in every difficulty.” -Winston Churchill

Ambition, fueled by compassion, wisdom, and integrity, is a powerful force for good that will turn the wheels of industry and open the doors of opportunity for you and countless others. -Zig Ziglar

46 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

“The reward for work well done is the opportunity to do more.” -Jonas Salk “In the middle of chaos lies opportunity.” -Bruce Lee “We should never lose an occasion. Opportunity is more powerful even than conquerors and prophets.” -Benjamin Disraeli “Failure is the opportunity to begin again more intelligently.” -Henry Ford

10 MOST VALUABLE

PHARMACEUTICAL

COMPANIES IN INDIA Brand

Name and Designation

Description

Alkem Laboratories

Sandeep Singh MD

A leading company that is engaged in the development, manufacturing, and sale of various nutraceutical and pharmaceutical products

Arch Pharmalabs

Ajit Kamath Executive Chairman & MD

A company engaged in the manufacturing and sale of APIs and intermediates to innovator and generic pharmaceutical players

Aurobindo Pharma

K. Ragunathan Director & NonExecutive Chairman

A company working in key therapeutic segments such as neurosciences (CNS), cardiovascular (CVS), anti-retroviral, antidiabetics, gastroenterology, and Anti-biotics

Cadila Pharmaceuticals

Dr. Rajiv Modi Chairman & MD

A well-known company dedicated to achieving continuous excellence in pharmaceuticals and life sciences

Divi’s Laboratories

Dr. Murali K. Divi Founder & MD

A leading manufacturer of APIs, intermediates, and registered starting materials offering high-quality products with the highest level of compliance

Indoco Remedies

Aditi Kare Panandikar MD

A fully integrated company engaged in the manufacturing and marketing of Finished Dosage Forms and APIs

Ipca Laboratories

Premchand Godha Chairman & MD

A consumer-led global pharmaceutical company that has become one of the world’s largest manufacturers and suppliers of APIs

Mankind Pharma

Ramesh C Juneja Founder & Executive Chairman

A leading company that desires to aid the community in leading a healthy life by formulating, developing, and delivering affordable medicines for needy

Sun Pharma

Dilip Shanghvi Founder & MD

A research-oriented company that provides high-quality, and affordable medicines to more than 100 countries worldwide

Zydus Cadila

Sharvil Patel MD

A company providing comprehensive and complete healthcare solutions ranging from APIs and animal healthcare products to wellness products

All the names have been arranged in an alphabetical order, and it is not a ranking TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 47

48 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 49

HEALTH

RAPPED T S T O O B Y THAT EVER OULD EAT H S R U E N E ENTREPR

ealth matters for everyone and that is why taking care of health is very important. Unfortunately, entrepreneurs are always on the go, be it running between important meetings or working for long hours in the office. They are among the worst to take care of themselves. Eating healthy and nutritious food becomes a challenge for them. But taking some time away from the office work and focusing on health can do wonders. Here is the list of 5 healthy foods that every bootstrapped entrepreneur should eat:

50 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

1. POTATOES

There must be a reason behind potatoes surviving in our diets for hundreds of years now. Potatoes are available worldwide and are very rich in nutrients and vitamins. They play a significant role in our nervous system and mental capacity as they are a rich source of Vitamin B6. It is also believed that a baked potato on a winter’s day makes a warming, economical, and nutritious treat for the body. According to research studies, one large potato contains 57 mg of choline which helps in muscles movement, learning, and memory. Potatoes also maintain the structure of cellular membranes, transmit nerve impulses, and help in early brain development and the absorption of fat.

2. BLACK BEANS

Entrepreneurs always run short on time and sometimes forget to eat food. This results in decreased productivity. Fortunately, we have black beans in the list. Black Beans are one of the best morning foods which not only eliminate hunger for a longer time but also provide energy for hours. Black Beans are low in sodium and contain potassium, magnesium, and calcium. All these traits help in decreasing blood pressure. Eating black beans also helps to prevent constipation and promote regularity for a healthy digestive system. Add black beans to your diet right away.

3. QUINOA

Another nutritious and hyped-up food for entrepreneurs can be quinoa. Quinoa contains all the necessary nutrients to keep the body healthy. It contains almost twice as much fiber as most other grains. It also helps in reducing blood pressure and diabetes. It also contains all the nine essential amino acids and is thus considered a protein-rich food. Quinoa is rich in magnesium which helps in body temperature regulation, the transmission of nerve impulses, energy production, detoxification, and the formation of healthy bones and teeth.

4. EGGS

Loaded with lots of nutrients, this superfood comes with 77 calories, 6 grams of protein, and 5 grams of healthy fats. Eggs contain 13 essential vitamins and minerals and 3 fatty acids and antioxidants. If you eat 2 eggs, that would mean fulfilling: 82% of daily vitamin D requirements, 25% of daily riboflavin (Vitamin B2) requirements, 40% of daily selenium requirements, and 50% of daily folate requirements. Most importantly, eggs keep energy levels higher, boost metabolic activity, and increase levels of a hormone that helps you feel satisfied after you finish eating.

5. LENTILS

According to a research by American Heart Association, increased fiber intake can reduce levels of cholesterol and low-density lipoprotein. Luckily, lentils are a plentiful source of fiber. Lentils come in red, green, brown, and black color and are a highly nutritious food. Taking 100 grams of cooked lentils would mean giving 116 calories (kcal), 0.38 g of fat, 9.02 g of protein, and 20.13 g of carbohydrates, including 7.9 g of fiber and 1.8 g of sugar to the body.

Thomas Carlyle has rightly said, “He who has health, has hope; and he who has hope, has everything.” A healthy mind can only live in a healthy body. So, without any delay, start taking these 5 food products in your diet to live a healthy and nutritious life.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 51

LIFESTYLE

TOP 5 EXPENSIVE

MOTOR BIKES IN THE WORLD

t is often said that four wheels move the body but two wheels move the soul. But, nowadays choosing the right motorcycle is becoming challenging for all the bike riders. Here we present some of the world’s most expensive motorbikes that can help you choose from the best. So, if you are ready to start off your engine, check out this list of the most expensive motorbikes:

1. Neiman Marcus Limited Edition Fighter – $11 million

The world’s most expensive motorbike is Neiman Marcus Limited Edition Fighter. It is designed by Neiman Marcus, an American chain of luxury departmental stores. The bike’s eye-catching chassis is carved out from a single piece of metal. Only 45 units of this fighter are released so far in the market. Despite its sky-touching value tag and average appearance, this bike is completely road legal, managing the road at 190 miles per hour. Its power comes from a 120ci 45-degree air-cooled V-Twin engine complemented by titanium, aluminum, and carbon fiber body parts.

52 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

2. 1949 E90 AJS Porcupine – $7 Million

With an amazing racing history, the 1949 E90 AJS Porcupine is extremely rare. It is famous because of the British Racer Leslie Graham who won the inaugural Grand Prix motorcycle racing 500 cc world championship in 1949 using one of these motorbikes. Only 4 Porcupine units have been produced so far. Vintage, exclusive, and world-famous are the three appropriate words that describe the characteristics of E90 AJS Porcupine.

3. Ecosse ES1 Spirit – $3.6 million

Popularly called as the superbike of superbikes, the Ecosse ES1 Spirit is one of the lightest and fastest motorbikes in the world. Designed by two top engineers, Richard Glover and Andy Le Fleming, Ecosse ES1 Spirit is a revolutionary motorcycle. It’s not that easy to ride this bike, even a professional rider requires at least 2 weeks of training to ride on Ecosse. Its speed comes from the ultra-light aerodynamic design and powerful engine. It weighs about 265 lbs and can go around 230 miles per hour. To ensure ergonomics and control, the bike is designed in such a way that the driver’s knees come close to the body.

4. Hildebrand & Wolfmuller – $3.5 million

Released in 1894, Hildebrand & Wolfemuller is the first production bike. Surprisingly, this bike does not have a clutch or a pedal. It has a very simple design, unlike other motorbikes but that does not make it a regular bike. Manufactured in Germany, it has the highest historical importance. Today, examples of this bike exist in top museums like the Science Museum in London and The Henry Ford in Detroit, Michigan.

5. Harley Davidson Cosmic Starship – $1.5 million Designed like flowing lava and handpainted by world-renowned artist, Jack Armstrong, this is one of the most popular bikes in the world. It was first introduced in October 2010 at Bartels in Marina Del Rey, California. Its sky-high cost is based on the fact that Armstrong painted it. If you have a spare of $1.5 million then Harley Davidson Cosmic Starship can be the perfect choice.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 53

THE ABODE OF THE CLOUDS

54 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

ntouched by the harshness of the modern-day vulnerabilities, Meghalaya is truly blessed by heavenly nature. This beautiful land is situated in the northeastern part of India and is derived from a Sanskrit word meaning ‘abode of clouds’. Clear rivers, lush green valleys, dense forests, beautiful plateaus, pine-covered hills, and varied biodiversity, make Meghalaya a perfect place to visit. Here is the list of top 5 places to visit in Meghalaya.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 55

1. Shillong

Shillong is the capital city of Meghalaya and is known for its pleasant climate, forested hills, and scenic beauty. Some of the famous places that you can explore in the capital city are Lady Hydari Park, Elephant Falls, Don Bosco Museum, Air Force Museum, All Saints Cathedral, and Shillong Peak. As the main airport of Meghalaya is in Shillong, you will find many things to explore here to make your holidays adventurous and exciting. The best time to visit this place is between September and May.

2. Cherrapunji

Cheerapunji is one of the wettest places on Earth as it receives the highest rainfall. It encompasses some of the best waterfalls in the world like the Dain-Thlen, Kynrem, and Nohkalikai waterfalls. You can spend your best time in Cheerapunji by visiting Double Decker Living Root Bridges, Wakaba Falls, Krem Mawmluh, Seven sisters falls, Eco-park, and a garden of caves. It is situated at a distance of about 56 km away from the capital city Shillong and at an altitude of about 4500 feet. The best season to visit Cheerapunji is winter, between October and February.

56 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

3. Tura

Located in the Garo Hills, Tura is famous for its serene environment. It is a paradise for wildlife enthusiasts and nature lovers. You must visit Mir Jumla’s Tomb, Siju Bird Sanctuary, Balpakram National Park, Nokrek National Park, Rongbang Dar Waterfall, Kata Beel, and Siju Caves if you plan to go to Tura. Shrouded with the fragrance of mountains and greenery, Tura is a place you can’t miss exploring. Tura’s weather stays cool during the day and chilly at night.

4. Kyllang Rock

Situated in the West Khasi Hills of Meghalaya, Kyllang Rock lies in the range of 78 km away from Shillong. It is an extraordinary rock made out of red stone with a width of around 1000 ft. Kyllang Rock is derived from the Khasi word Kylla Lang. A climb to the highest point of this rock allows anyone to cherish the mesmerizing scene of the encompassing zone.

5. Umiam Lake

With an accumulated catchment area of 222 sq km, Umiam Lake is one of the largest manmade lakes built on the Umiam River. It is also known as Barapani or Big Water and is situated 15 kilometers north of Shillong. You can take a long boat ride in the lake and appreciate drifting and different water sports. The time required to cover the entire lake is 1 to 2 hours. Except these 5 places, you can also visit Jowai, Dawki, Nongpoh, and other nearby places in Meghalaya. If you are searching for a destination that can give you some inner peace and harmony, then Meghalaya is the perfect destination. Consider holidaying in this beautiful place right away.

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 57

58 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021

THINKING ABOUT

PROMOTING YOUR BRAND

TALK TO US! THE

The choice is yours

Contact:- +91 9871258991

WORLD MEETS MEDIA

Email:- PR@theglobalhues.com

TheGlobalHues | Vol. 1 | Issue 15 | October 2021

| 59

From National To Global We Engage With People To Tell Their Stories

THANK YOU FOR READING

Subscribe to our E-Magazine NOW! Visit www.theglobalhues.com

60 | TheGlobalHues | Vol. 1

| Issue 15 | October 2021